Helicobacter pylori Treatment
Helicobacter pylori infection
CommercialActive
Key Facts
About OFD Biopharma
OFD Biopharma, a division of OFD Life Sciences, is a US-based CDMO providing expert lyophilization solutions to stabilize complex pharmaceuticals. The company differentiates itself through its focus on bulk lyophilization and proprietary platforms like LyoLock and LyoPastille, which aim to enhance drug stability, solubility, and bioavailability. It offers end-to-end support from R&D through commercialization, serving clients in oncology, immunology, and other therapeutic areas. As a private service provider, its financial model is based on client contracts and project milestones.
View full company profileOther Helicobacter pylori infection Drugs
| Drug | Company | Phase |
|---|---|---|
| HELIX | Lant Medical | Pre-clinical |
| Linaprazan Glurate | Cinclus Pharma | Unknown |
| JP-1366 | Livzon Pharmaceutical | IND |
| TNP-2198 (利福特尼唑) | TenNor Therapeutics | Phase 3 |